UK research project secures EPSRC grant for medicine development
Pharmaceutical Technology
MAY 9, 2024
A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
MAY 9, 2024
A research project between DMU and the University of Surrey received a grant to help reduce costs for companies in developing medicines.
Bio Pharma Dive
JUNE 27, 2024
A growing cohort of biotechs, from Biohaven to Neurocrine to Jazz, hope research on ion channels will bring them new drugs and big business — much like it has done for Vertex.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
APRIL 24, 2023
Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture.
AuroBlog - Aurous Healthcare Clinical Trials blog
MAY 16, 2023
In a move to strengthen the country’s health infrastructure and to integrate and mainstream Ayush sector, the Ministry of Ayush and the Indian Council of Medical Research (ICMR) have signed a Memorandum of Agreement (MoA).The The MoA is for collaboration and cooperation in health research in the field of integrated medicine.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 10, 2024
By focusing on clinical excellence, comprehensive education, and cutting-edge research, the Arya Vaidya Pharmacy Research Foundation (AVPRF) based in Coimbatore is ensuring that ayurvedic practices are validated, credible, and relevant for future generations.
Pharmaceutical Technology
JANUARY 31, 2024
Regeneron Pharmaceuticals has formed Regeneron Cell Medicines, a new research & development (R&D) unit in oncology and immunology.
Drug Discovery World
JANUARY 25, 2024
US company Vaxxinity and the University of Central Florida (UCF) have announced plans to work together to advance space medicine research. The research, funded by a grant from the State of Florida, aims to develop Vaxxinity’s active immunotherapies to prevent and mitigate muscle and bone wasting.
pharmaphorum
JANUARY 4, 2024
In today’s podcast, web editor Nicole Raleigh speaks with Dr Pandora Pound, a Fellow at the OCAE and research director at the Safer Medicines Trust, a charity aiming to improve the safety of medicines by facilitating a transition to human biology-based drug development and testing.
Pharmaceutical Technology
MAY 14, 2024
Dandelion Health’s database can be used as a tool for sponsors to decide which indications to next investigate GLP1-RAs in.
Pharma Times
APRIL 12, 2024
Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions
Pharmaceutical Technology
DECEMBER 23, 2022
Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology.
Antidote
NOVEMBER 14, 2023
That interest influenced her career trajectory, and she’s now a leading investigator at Benaroya Research Institute where she has studied the natural history of type 1 diabetes (T1D) since 2000. For Carla Greenbaum, M.D., growing up in the era of space travel and the moon landing kindled a lifelong interest in science.
Pharmaceutical Technology
OCTOBER 2, 2023
The Physiology and Medicine Prize has gone to two researchers whose work laid the foundation for Pfizer and Moderna’s Covid-19 vaccines.
pharmaphorum
JUNE 13, 2024
In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the IQVIA Institute for Human Data Science, to discuss the state of global medicines and the future outlook when it comes to research and development, and usage and spending appetites. (..)
STAT News
OCTOBER 3, 2022
A Swedish scientist won the 2022 Nobel Prize in medicine or physiology on Monday for his groundbreaking research into the evolutionary history of humankind.
Pharmaceutical Technology
JUNE 20, 2023
The Department of Health Abu Dhabi (DoH) has signed a memorandum of understanding with integrated healthcare company M42 and AbbVie Biopharmaceuticals to advance personalised medicine and genomics in the city. M42 was created through the combination of Mubadala Health and G42 Healthcare.
Drug Discovery World
JANUARY 16, 2023
BioGrad, a company offering medical and scientific support for education and research organisations, is to open the UK’s second largest biobank facility in Liverpool, as part of a £7.6m The post New UK biobank offers stem cell and regenerative medicine research potential appeared first on Drug Discovery World (DDW).
Pharmaceutical Technology
JUNE 8, 2023
Biotechnology company Hopewell Therapeutics has raised $25m in seed financing to accelerate the development of next-generation lipid nanoparticles for targeted delivery of genomic medicines. Hopewell Therapeutics is engaged in discovering, synthesising and developing advanced ttLNPs to provide next-generation genomic medicines.
Rethinking Clinical Trials
FEBRUARY 28, 2024
In this Friday’s PCT Grand Rounds, Joseph Doyle of the Massachusetts Institute of Technology (MIT) will present “Effect of an Intensive Food-as-Medicine Program on Health and Healthcare Use: Evidence From a Randomized Clinical Trial.” ” The Grand Rounds session will be held on Friday, March 1, 2024, at 1:00 pm eastern.
Rethinking Clinical Trials
AUGUST 3, 2023
Bergstrom, PhD Professor, Department of Biology University of Washington Slides Keywords Research, Misinformation, Media, Social Media Key Points Misinformation abounds in medicine and about medicine. As researchers, we are producers and consumers of the medical literature. It is important to avoid hype.
Pharmaceutical Technology
MARCH 24, 2023
Moderna has entered a strategic partnership with Generation Bio for the development of non-viral genetic medicines. Moderna’s biological and technical expertise will be combined with core technologies of the non-viral genetic medicine platform from Generation Bio.
Pharmaceutical Technology
FEBRUARY 27, 2023
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorisation for Me rck and Ridgeback Biotherapeutics’ Lagevrio (molnupiravir). Merck and Ridgeback intend to appeal the decision and request a re-examination of the regulator’s opinion.
Pharmaceutical Technology
NOVEMBER 21, 2022
RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore.
Medical Xpress
MARCH 21, 2023
While listening to a favorite song is a known mood booster, researchers at Michigan State University have discovered that music-listening interventions also can make medicines more effective.
Drug Discovery World
JUNE 29, 2023
Cancer Research UK has joined the PRIME-ROSE project, a Europe-wide effort to boost patient access to precision cancer medicine (PCM). ” The post Cancer Research UK joins precision cancer medicine consortium appeared first on Drug Discovery World (DDW).
World of DTC Marketing
DECEMBER 4, 2020
Digital medicine has been thrust into the spotlight because of the pandemic and the media hype is in overdrive. According to CB Insights , a research firm, a record $8.4bn of equity funding flowed into privately-held digital-health darlings in the third quarter of 2020, more than double the amount a year ago because nobody wants to miss out.
Scienmag
FEBRUARY 15, 2022
[New York, February 15, 2022] – Amit Bar-Or, MD, of the University of Pennsylvania, is this year’s recipient of the Barancik Prize for Innovation in MS Research for work uncovering how the immune system drives multiple sclerosis and cutting-edge research focusing on precision medicine to achieve long-term remission and ultimately preventing progression (..)
Bio Pharma Dive
MAY 19, 2023
The biotech, best known for its vaccine research, said its clinical trial is the first to report results of a messenger RNA therapeutic designed for intracellular protein replacement.
Rethinking Clinical Trials
MAY 3, 2023
Joshua Denny, All of Us Research Program (Photo: Vanderbilt University Medical Center) In this Friday’s PCT Grand Rounds, Joshua Denny of the All of Us Research Program at NIH, will present “ All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine.”
BioSpace
MAY 27, 2024
With medicine becoming more specialized and clinical trial protocols increasingly complex, we need to think about how to drive efficiencies to overcome these challenges and keep up the pace of research.
Bio Pharma Dive
OCTOBER 19, 2023
The base editing specialist will prioritize medicines for sickle cell and alpha-1 antitrypsin deficiency, while trimming its plans for other programs in cancer and hepatitis B.
BioPharma Reporter
MAY 7, 2021
Sanofi and Stanford University School of Medicine have established a three-year research collaboration: focusing on autoimmune diseases and inflammatory conditions.
Pharmaceutical Technology
AUGUST 11, 2022
Gemini Therapeutics has signed a definitive agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical company. The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US. To back the merger, Disc raised funds worth $53.5m
Rethinking Clinical Trials
JUNE 29, 2023
Joshua Denny as he discusses improving health through the All of Us research program. The post Podcast June 12, 2023: All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine (Joshua Denny, MD, MS) appeared first on Rethinking Clinical Trials. Read the transcript.
Pharmaceutical Technology
FEBRUARY 6, 2023
Researchers at the Feinstein Institutes for Medical Research have discovered a new protein that can be a potential therapeutic target for lethal sepsis. Led by Feinstein Institutes researcher Haichao Wang, the new study focuses on detecting protein mediators that might contribute to uncontrolled immune responses to lethal infections.
Bio Pharma Dive
MARCH 1, 2024
Reeling from a difficult year financially, the pharma unveiled a new oncology division it says will produce eight billion-dollar medicines by 2030.
Pharma Mirror
SEPTEMBER 27, 2021
The DREAM study is an observational, non-pharmacologic and non-interventional clinical study initiated by certain researchers participating in the. The DREAM study is an observational, non-pharmacologic and non-interventional clinical study initiated by certain researchers participating in the.
Scienmag
APRIL 14, 2022
In a Policy Forum, Anna Lewis and colleagues argue that, for researchers and others who want to invoke genetic ancestry, there is a scientific and ethical imperative to move away from continental ancestry categories and to instead embrace a view of genetic ancestry that reflects continuous variation and historical depth.
Drug Discovery World
MAY 17, 2024
PlaqueTec and the Welch research group at the Babraham Institute have announced the completion of their collaboration to evaluate lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec. The post Partners explore precision medicine approach to heart disease appeared first on Drug Discovery World (DDW).
Outsourcing Pharma
JUNE 11, 2024
announced the publication of groundbreaking research in the European Society of Medicine Journal. Yesterday (June 10) IGC Pharma, Inc.
Outsourcing Pharma
JUNE 11, 2024
announced the publication of groundbreaking research in the European Society of Medicine Journal. Yesterday (June 10) IGC Pharma, Inc.
Medical Xpress
APRIL 6, 2023
director of the Wound Healing and Regenerative Medicine Research Program at the University of Miami Miller School of Medicine, were launched to the International Space Station for advanced testing as part of a research voyage by CUTISS, a Swiss life sciences company.
Scienmag
JUNE 13, 2022
Reston, VA — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) today announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.
Velocity Clinical Research
NOVEMBER 21, 2023
“Without clinical research, there would be little if any development of new medicines,” says Isabelle Schenkenberger, MD. I’m proud and excited to be a part of it.” Dr. Schenkenberger is especially proud of her clinical trial research work in heart health, noting most new drugs never make it to market.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content